Gastrointestinal bleeding and subsequent risk of thromboembolic events during support with a left ventricular assist device

Patients who had GI bleeding were at significantly higher risk for a subsequent TE event. Although the exact cause of this relationship is unknown, it suggests that a reduction in anti-coagulation and anti-platelet management to treat GI bleeds may contribute to this risk.